Education
About Us
Working with TipRanks
Follow Us
Globus Medical (GMED)
:GMED
GMED Stock Chart & Stats
Day’s Range― - ―
52-Week Range$51.79 - $94.93
Previous CloseN/A
Volume442.39K
Average Volume (3M)1.50M
Market Cap
$7.26B
Enterprise Value$9.86B
Total Cash (Recent Filing)$461.27M
Total Debt (Recent Filing)$92.31M
Price to Earnings (P/E)39.5
Beta0.91
Next Earnings
Nov 11, 2025EPS Estimate
0.8Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.86
Shares Outstanding112,949,280
10 Day Avg. Volume1,252,544
30 Day Avg. Volume1,497,609
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.36
Enterprise Value/Revenue3.93
Enterprise Value/Gross Profit6.89
Enterprise Value/Ebitda20.27
Forecast
1Y Price Target
$82.33Price Target Upside53.49% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe reaffirmation of FY25 guidance suggests confidence in the company's future performance despite recent changes.
Leadership StabilityWith Globus founder David Paul remaining as Executive Chairman and Pfeil's promotion bringing further continuity, analysts feel comfortable for now in GMED's direction and reiterate a BUY recommendation.
Sales GrowthGMED announced preliminary Q2/25 sales to be an as-reported increase of +18.4% year-over-year.
Bears Say
Market ConcernsThe unexpected management change at Globus Medical has raised concerns among investors.
Market EnvironmentThe challenging market environment and the need for significant growth in the Spine business make it difficult for Globus Medical to meet its guidance.
Sales PerformanceThe base business of Globus Medical showed weaker-than-expected sales, missing analyst expectations.
Globus Medical News
GMED FAQ
What was Globus Medical’s price range in the past 12 months?
Globus Medical lowest stock price was $51.79 and its highest was $94.93 in the past 12 months.
What is Globus Medical’s market cap?
Globus Medical’s market cap is $7.26B.
When is Globus Medical’s upcoming earnings report date?
Globus Medical’s upcoming earnings report date is Nov 11, 2025 which is in 95 days.
How were Globus Medical’s earnings last quarter?
Globus Medical released its earnings results on Aug 07, 2025. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.753 by $0.107.
Is Globus Medical overvalued?
According to Wall Street analysts Globus Medical’s price is currently Undervalued.
Does Globus Medical pay dividends?
Globus Medical does not currently pay dividends.
What is Globus Medical’s EPS estimate?
Globus Medical’s EPS estimate is 0.8.
How many shares outstanding does Globus Medical have?
Globus Medical has 112,949,280 shares outstanding.
What happened to Globus Medical’s price movement after its last earnings report?
Globus Medical reported an EPS of $0.86 in its last earnings report, beating expectations of $0.753. Following the earnings report the stock price went down -22.964%.
Which hedge fund is a major shareholder of Globus Medical?
Currently, no hedge funds are holding shares in GMED
Globus Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$82.33 (53.49% Upside)
$82.33 (53.49% Upside)
Blogger Sentiment
Bullish
GMED Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 173.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 5.3%
Last 30 Days ▼ 5.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.49%
12-Months-Change
Fundamentals
Return on Equity
4.63%
Trailing 12-Months
Asset Growth
-4.70%
Trailing 12-Months
Company Description
Globus Medical
Globus Medical (GMED) is a leading medical device company specializing in the design, development, and commercialization of healthcare solutions, primarily in the musculoskeletal sector. The company's core products include a wide range of innovative and technologically advanced devices for spinal surgery, trauma, and orthopedic applications. Globus Medical is recognized for its commitment to improving patient care through high-quality, state-of-the-art products that address a variety of clinical needs.
GMED Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed performance, with strong cash flow, debt repayment, and new product launches being significant positives. However, flat sales, a substantial decline in enabling technology sales, and supply chain disruptions presented notable challenges. The acquisition of Nevro offers future growth opportunities, but the current quarter's results indicate areas needing improvement.View all GMED earnings summariesGMED Net sales Breakdown
92.34% Musculoskeletal Solutions
7.66% Enabling Technologies
GMED Stock 12 Month Forecast
Average Price Target
$82.33
▲(53.49% Upside)
Technical Analysis
Ownership Overview
0.72% Insiders
31.23% Mutual Funds
1.22% Other Institutional Investors
44.27% Public Companies and
Individual Investors